Plexision

Plexision currently offers a wide range of laboratory-developed cell-based diagnostic tests for personalized patient care. The proprietary technology underlying these testing systems has been utilized to support tailored R&D projects in both industry and academia.Plexision's first product, the FDA-approved Pleximmune TM blood test, predicts transplant rejection. The latest blood test, PlexCOVID-19, assesses the risk and severity of COVID-19 infection.